Produkty 181229-50-5

CAS 181229-50-5 to numer rejestracyjny substancji 21-(3-Carboxy-1-oxopropoxy)-11,17-dihydroxy-(11beta,17alphalpha)-Pregn-4-ene-3,20-dione. Oferty producentów: TRC. Dostępne opakowania: 25mg.

21-(3-Carboxy-1-oxopropoxy)-11,17-dihydroxy-(11beta,17alphalpha)-Pregn-4-ene-3,20-dione
TRC
  • opakowanie: 25mg
  • Warianty: 1
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

4-[2-[(8S,9S,10R,11S,13S,14S,17S)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoic acid (CAS 181229-50-5) to związek chemiczny o wzorze sumarycznym C25H34O8 i masie molowej 462.5 g/mol. Nazwa systematyczna IUPAC: 4-[2-[(8S,9S,10R,11S,13S,14S,17S)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoic acid. InChIKey: VWQWXZAWFPZJDA-RRDJUGERSA-N.

Dane identyfikacyjne
Wzór sumarycznyC25H34O8
Masa molowa462.5 g/mol
Nazwa IUPAC4-[2-[(8S,9S,10R,11S,13S,14S,17S)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoic acid
InChIKeyVWQWXZAWFPZJDA-RRDJUGERSA-N
SMILESC[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@]4(C(=O)COC(=O)CCC(=O)O)O)C)O

Dane obliczone przez PubChem (NCBI)

Synonimy: 21-(3-Carboxy-1-oxopropoxy)-11,17-dihydroxy-(11?,17?)-Pregn-4-ene-3,20-dione
Powiązane formy tego związku
4-[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoic acid C25H34O8
4-[2-[(8S,9S,10R,11R,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoic acid C25H34O8
Izomery (ten sam wzór sumaryczny)
(2R,3R,4S,5S,6R)-2-[1,7-bis(4-hydroxyphenyl)heptan-3-yloxy]-6-(hydroxymethyl)oxane-3,4,5-triol C25H34O8
4-[[(8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]oxy]-4-oxobutanoic acid C25H34O8
(2S,3S,4S,5R,6R)-6-[[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid C25H34O8
(2S,3S,4S,5R,6R)-6-[[(8R,9S,10R,13S,14S,17R)-10,13-dimethyl-3-oxo-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid C25H34O8